X0508 4 2026-02-12 0 0001101026 Zivo Bioscience, Inc. ZIVO 0000919484 STROME MARK E 1688 MERIDIAN AVENUE, SUITE 727 MIAMI BEACH FL 33139 0 0 1 0 0000936711 STROME INVESTMENT MANAGEMENT LP C/O STROME GROUP, INC. 14120 VENTURA BLVD., STE C-525 SHERMAN OAKS CA 91423 0 0 0 1 Affiliate of 10% Owner 0001724136 STROME GROUP, INC. 14120 VENTURA BLVD., STE C-525 SHERMAN OAKS CA 91423 0 0 0 1 Affiliate of 10% Owner 0 Common Stock 2026-02-12 4 P 0 20000 9.77 A 472942 I By entity Common Stock Purchase Warrant 9.77 2026-02-12 4 P 0 2000 0 A 2026-02-12 2031-02-11 Common Stock 2000 45071 I By entity The reported securities are owned directly by Strome Mezzanine Fund II, LP ("SMF II"), which were acquired pursuant to a Securities Purchase Agreement that SMF II entered into with the issuer. Strome Investment Management, LP is the general partner of SMF II. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for and to beneficially own the shares held by SMF II under Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein. /s/ Mark E. Strome 2026-02-17 /s/ Mark E. Strome, as President of General Partner, on behalf of Strome Investment Management, LP 2026-02-17 /s/ Mark E. Strome, as President of General Partner, on behalf of Strome Group, Inc. 2026-02-17